Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue
April 1 (Reuters) - Devyser Diagnostics AB DVYSR.ST: COMPLETES ACQUISITION OF CYBERGENE AB AND CARRIES OUT ISSUE OF COMPENSATION SHARES ISSUES 124,363 NEW SHARES TO LEVEL BIO AB SUBSCRIPTION PRICE FOR NEW SHARES SET AT ABOUT SEK 98.29 PER SHARE SHARE ISSUE RESULTS IN ABOUT 0.74% DILUTION Source text: ID:nMFN7kkM33 Further company coverage: DVYSR.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Devyser Diagnostics AB
See all newsBrief: Devyser Awarded Tender In Italy Valued At SEK 8.9 Million
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue